What is JBIO's change in lease liabilities?

JBIO (JBIO) reported change in lease liabilities of -$29K in Q1 2026.

What does change in lease liabilities mean?

Cash payments for operating leases reducing the lease liability, partially offset by new lease commencements.

JBIO JBIO Change in Lease Liabilities

Change in Lease Liabilities at other companies

Vera TherapeuticsVERA

-$182K+53.8%

AnaptysBio, Inc.ANAB

-$499K-8.0%

Vor BiopharmaVOR

-$61K+94.2%

Alumis Inc.ALMS

-$1.25M-102%

TG TherapeuticsTGTX

-$424K+21.9%

Apogee Therapeutics, Inc.APGE

-$802K+20.9%

Other financials

Income statement

See full

Operating income-$43.4M-85.8%

Net income-$40.4M-5.8%

EPS (diluted)-$0.57+95.3%

Balance sheet

See full

Cash & equivalents$55.1M+24.6%

Total debt$808.0K+159%

Total equity$296.5M+455%

Total assets$319.4M+312%

Cash flow

See full

Operating cash flow-$24.1M-28.4%

CapEx$3.0K—

Free cash flow-$33.7M—

Valuation

See full

Market cap$1.33B+318%

Enterprise value$1.28B—

Returns & leverage

See full

Return on equity-132.5%+120pp

Debt / equity0×—

Current ratio14.3×-17.7×

Where this comes from

Reported directly by JBIO in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.

The official record: JBIO’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about JBIO's change in lease liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is JBIO's change in lease liabilities?: JBIO (JBIO) reported change in lease liabilities of -$29K in Q1 2026.
What does change in lease liabilities mean?: Cash payments for operating leases reducing the lease liability, partially offset by new lease commencements.